Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-10-26 Governance Information
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for related party transactions of Ningbo New Gene Bio-tech Co., Ltd. It details the company's internal rules and procedures regarding related party transactions, including definitions, principles, decision-making authority, disclosure obligations, and board and shareholder meeting voting rules. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Beijing Stock Exchange. The document is a formal policy or governance document rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements or audit results. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-26 Chinese
承诺管理制度
Board/Management Information Classification · 95% confidence The document is a formal announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the adoption of a 'Commitment Management System' by the company's board of directors. It details the content and obligations related to commitments made by controlling shareholders, actual controllers, and related parties, including legal and regulatory compliance. The document includes voting results from the board meeting and states that the system will be submitted to the shareholders' meeting for approval. There are no financial statements, earnings data, or audit information present. The document is not a report itself but an announcement of a governance-related policy adopted by the board. This fits best under 'Board/Management Information (MANG)' as it concerns board resolutions and governance policies. The document length is under 5,000 characters and contains detailed policy content rather than a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the classification is MANG with high confidence.
2023-10-26 Chinese
独立董事工作制度
Governance Information Classification · 100% confidence The document is a detailed corporate governance policy specifically about the independent directors' working system at Ningbo New Gen Bio-Tech Co., Ltd. It outlines the qualifications, duties, nomination, election, and responsibilities of independent directors, as well as the company's support for them. The document references relevant laws, stock exchange rules, and company bylaws. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length and content confirm it is the actual policy document, not just an announcement or summary.
2023-10-26 Chinese
第八届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the supervisory board of Ningbo New Zhi Biotechnology Co., Ltd. It details the convening and attendance of the eighth supervisory board's sixth meeting, and the approval of the company's 2023 third quarter report. The document references the actual 2023 third quarter report published separately on the Beijing Stock Exchange information disclosure platform, indicating this document is not the report itself but a resolution regarding it. The document length is short (1170 characters) and it does not contain substantive financial data or analysis, only the supervisory board's review and approval of the quarterly report. Therefore, it is not the Interim/Quarterly Report (IR) itself but rather a Regulatory Filing (RNS) announcing the supervisory board's resolution and review of the quarterly report.
2023-10-26 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for external guarantees by Ningbo New Gen Bio-Tech Co., Ltd., including governance, approval procedures, responsibilities, and compliance with laws. It is a corporate governance policy document rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement or a certification. The content focuses on governance rules and procedures related to external guarantees, which fits best under Governance Information (CGR). The document length (5956 characters) supports it being a full policy document rather than a brief announcement.
2023-10-26 Chinese
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2023 年第三季度报告" which translates to "2023 Third Quarter Report". It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on significant events during the quarter. The document explicitly states it is a quarterly report (第三季度报告) and includes comprehensive financial statements and analysis for the period ending September 30, 2023. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (15,000 characters) and the presence of detailed financial data confirm it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.